Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel Disease
Remi Mahmoud(University Medical Center Utrecht), Bas Oldenburg(University Medical Center Utrecht), Dilek Akol-Simsek, Frank Hoentjen(Radboud University Nijmegen), Itta M. Minderhoud(Tergooi), Carmen S. Horjus‐Talabur Horje(Rijnstate Hospital), Ben Witteman(Ziekenhuis Gelderse Vallei), Sebastiaan A.C. van Tuyl, Nofel Mahmmod(St. Antonius Ziekenhuis), Maurice Lutgens(Elisabeth-TweeSteden Ziekenhuis), Edo Savelkoul(Radboud University Nijmegen), Rogier Goetgebuer(Erasmus MC), Bindia Jharap(Meander Medisch Centrum), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), D.B. de Koning, Jeroen M. Jansen(OLVG), Herma H. Fidder(University Medical Center Utrecht), Petra G.A. van Boeckel(St. Antonius Ziekenhuis), Fiona D M van Schaik(University Medical Center Utrecht), Wout Mares(Ziekenhuis Gelderse Vallei), Jean‐Frédéric Colombel(Mount Sinai Hospital)
Cited by 18
Related Papers
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k